Behbahani Ali
Insider CIK 1613867 · MRKR 10% owner · SVRA 10% owner · CVRX Director · NVRO Director · UTRS Director · GNCA Director, 10% owner · RGLS 10% owner · TRVI 10% owner · ADAP Director · MTCR 10% owner · BHG Director, 10% owner · CRSP Director · BDTX Director · KRRO Director, 10% owner · OYST Director · AKUS 10% owner · MIRM 10% owner · MBX 10% owner · SGP Director, 10% owner · ACLX Director · NKTK Director · GLUE Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BDTX Black Diamond Therapeutics | A Award | 2026-09-18 | 2026-09-21 | 7,707 | $1.93 | $14.9K | 110,236 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2026-09-18 | 2026-09-21 | 7,707 | $1.93 | $14.9K | 110,236 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-09-17 | 2026-09-21 | 30,000 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-09-17 | 2026-09-21 | 30,000 | $14.00 | $420.0K | 30,316 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-09-17 | 2026-09-21 | 13,679 | $57.09 | $780.9K | 16,637 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-09-17 | 2026-09-21 | 30,000 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-09-17 | 2026-09-21 | 13,679 | $57.09 | $780.9K | 16,637 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-09-17 | 2026-09-21 | 30,000 | $14.00 | $420.0K | 30,316 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2026-07-01 | 2026-07-06 | 1,000,000 | — | $0 | 6,692,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2026-07-01 | 2026-07-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | J Other | 2026-07-01 | 2026-07-06 | 15,000 | — | $0 | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2026-06-26 | 2026-06-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2026-06-19 | 2026-06-22 | 8,961 | $1.66 | $14.9K | 102,529 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2026-06-11 | 2026-06-12 | 25,800 | — | $0 | 25,800 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 37,000 | — | $0 | 37,000 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 14,677 | — | $0 | 14,677 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-06-05 | 2026-06-09 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ACLX Arcellx, Inc. | D To issuer deriv | 2026-04-28 | 2026-04-28 | 8,011 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | D To issuer deriv | 2026-04-28 | 2026-04-28 | 9,174 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | D To issuer deriv | 2026-04-28 | 2026-04-28 | 11,459 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | U Tender | 2026-04-28 | 2026-04-28 | 1,925 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | U Tender | 2026-04-28 | 2026-04-28 | 2,706 | — | $0 | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2026-03-20 | 2026-03-20 | 6,919 | $2.15 | $14.9K | 93,568 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2026-03-10 | 2026-03-12 | 242,945 | $11.11 | $2.70M | 242,945 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award | 2026-03-10 | 2026-03-12 | 207,100 | $11.11 | $2.30M | 1,297,893 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,619,240 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 737,962 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 402,273 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 954,990 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 954,990 | — | $0 | 954,990 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,619,240 | — | $0 | 1,619,240 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 2,989,408 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 4,359,576 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 737,962 | — | $0 | 5,097,538 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | P Buy | 2026-02-09 | 2026-02-11 | 937,500 | $16.00 | $15.00M | 6,035,038 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 402,273 | — | $0 | 1,357,263 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | A Award deriv | 2026-02-05 | 2026-02-09 | 27,400 | — | $0 | 27,400 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2025-12-12 | 2025-12-15 | 5,208 | $2.76 | $14.4K | 86,649 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 37,700 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 75,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 186,128 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 186,128 | — | $0 | 186,128 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 189,195 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 372,255 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 372,255 | — | $0 | 372,255 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 189,195 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 100,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 125,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 124,085 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 124,085 | — | $0 | 124,085 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 607,536 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise deriv | 2025-10-02 | 2025-10-06 | 1,656,789 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 280 | $6.75 | $1.9K | 787,979 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 189,195 | $0.01 | $1.9K | 788,259 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 900 | $6.75 | $6.1K | 2,260,970 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 182 | $6.75 | $1.2K | 2,384,873 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 124,085 | $0.01 | $1.2K | 2,385,055 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 372,255 | $0.01 | $3.7K | 1,160,234 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 551 | $6.75 | $3.7K | 1,159,683 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 1,159,683 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 189,195 | $0.01 | $1.9K | 488,982 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 280 | $6.75 | $1.9K | 488,702 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 186,128 | $0.01 | $1.9K | 674,830 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 276 | $6.75 | $1.9K | 674,554 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 674,554 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 1,656,789 | $0.01 | $16.6K | 1,656,789 | SEC↗ |
| NEUE NeueHealth, Inc. | S Sale | 2025-10-02 | 2025-10-06 | 2,455 | $6.75 | $16.6K | 1,654,334 | SEC↗ |
| NEUE NeueHealth, Inc. | X Exercise | 2025-10-02 | 2025-10-06 | 607,536 | $0.01 | $6.1K | 2,261,870 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 2,384,873 | — | $0 | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2025-09-19 | 2025-09-22 | 4,291 | $3.35 | $14.4K | 81,441 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-08-18 | 2025-08-19 | 14,671,794 | $0.01 | $146.7K | 0 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-08-15 | 2025-08-19 | 4,828,206 | $0.01 | $48.3K | 14,671,794 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2025-08-12 | 2025-08-14 | 1,586 | — | $0 | 1,925 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2025-08-12 | 2025-08-14 | 2,621 | — | $0 | 2,706 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2025-08-06 | 2026-09-21 | 15 | — | $0 | 29 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2025-08-06 | 2026-09-21 | 60 | — | $0 | 316 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2025-08-06 | 2026-09-21 | 15 | — | $0 | 29 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2025-08-06 | 2026-09-21 | 60 | — | $0 | 316 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2025-06-20 | 2025-06-20 | 6,170 | $2.33 | $14.4K | 77,150 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2025-06-13 | 2025-06-16 | 30,700 | — | $0 | 30,700 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2025-06-12 | 2025-06-12 | 30,550 | — | $0 | 30,550 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 6,010 | — | $0 | 6,010 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-06-05 | 2025-06-06 | 13,000 | — | $0 | 13,000 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 46,000 | — | $0 | 46,000 | SEC↗ |
| ACLX Arcellx, Inc. | A Award deriv | 2025-05-29 | 2025-05-30 | 9,174 | — | $0 | 9,174 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2025-03-21 | 2025-03-21 | 7,646 | $1.88 | $14.4K | 70,980 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2024-12-23 | 2024-12-23 | 554,250 | $3.20 | $1.77M | 1,625,678 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2024-12-13 | 2024-12-16 | 5,750 | $2.50 | $14.4K | 63,334 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 61,865 | — | $0 | 185,594 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 61,865 | — | $0 | 185,594 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-10-01 | 2024-10-03 | 185,595 | — | $0 | 556,782 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2024-09-20 | 2024-09-20 | 3,007 | $4.78 | $14.4K | 57,584 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-07-01 | 2024-07-01 | 1,144,686 | — | $0 | 1,144,686 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2024-06-21 | 2024-06-21 | 2,887 | $4.98 | $14.4K | 54,577 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 22,500 | — | $0 | 22,500 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-06-12 | 2024-06-13 | 22,100 | — | $0 | 22,100 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2024-06-11 | 2024-06-12 | 5,190 | — | $0 | 5,190 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2024-06-06 | 2024-06-06 | 30,550 | — | $0 | 30,550 | SEC↗ |
| CVRX CVRx, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 20,961 | — | $0 | 20,961 | SEC↗ |
| CVRX CVRx, Inc. | A Award deriv | 2024-06-04 | 2024-06-07 | 27,250 | — | $0 | 27,250 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-05-30 | 2024-05-31 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ACLX Arcellx, Inc. | A Award deriv | 2024-05-28 | 2024-06-06 | 8,011 | — | $0 | 8,011 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award | 2024-04-22 | 2024-04-24 | 17,857 | $56.00 | $1000.0K | 1,090,793 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 123,729 | — | $0 | 123,729 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 371,187 | — | $0 | 371,187 | SEC↗ |
| NEUE NeueHealth, Inc. | P Buy deriv | 2024-04-08 | 2024-04-10 | 123,729 | — | $0 | 123,729 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2024-03-15 | 2024-04-03 | 3,166 | $4.54 | $14.4K | 51,690 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-01-15 | 2024-01-17 | 40,950 | — | $0 | 40,950 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-12-19 | 2023-12-21 | 175,525 | — | $0 | 1,656,789 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2023-12-15 | 2023-12-15 | 4,455 | $2.73 | $12.2K | 48,524 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise deriv | 2023-12-14 | 2023-12-18 | 316 | — | $0 | 0 | SEC↗ |
| CVRX CVRx, Inc. | M Exercise | 2023-12-14 | 2023-12-18 | 316 | $0.24 | $76 | 316 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2023-11-03 | 2023-11-07 | 16,000 | — | $0 | 16,000 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award | 2023-11-03 | 2023-11-07 | 1,072,936 | — | $0 | 1,072,936 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-10-31 | 2023-11-02 | 100,606 | — | $0 | 1,481,264 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-09-15 | 2023-09-19 | 552,263 | — | $0 | 1,380,658 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2023-09-15 | 2023-09-18 | 3,299 | $3.60 | $11.9K | 44,069 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2023-08-11 | 2023-08-15 | 828,395 | — | $0 | 828,395 | SEC↗ |
| SVRA Savara Inc | P Buy | 2023-07-17 | 2023-07-19 | 333,333 | $3.00 | $1000.0K | 24,471,264 | SEC↗ |
| BDTX Black Diamond Therapeutics | P Buy | 2023-07-05 | 2023-07-06 | 1,000,000 | $5.00 | $5.00M | 4,448,757 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2023-07-03 | 2023-07-03 | 933,317 | — | $0 | 933,317 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2023-06-16 | 2023-06-16 | 5,655 | $2.10 | $11.9K | 40,770 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2023-06-14 | 2023-06-15 | 20,500 | — | $0 | 20,500 | SEC↗ |
| ACLX Arcellx, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 11,459 | — | $0 | 11,459 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 2,000,000 | — | $0 | 2,186,243 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 135 | — | $0 | 135 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 30,000 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2023-06-08 | 2023-06-09 | 13,000 | — | $0 | 13,000 | SEC↗ |
| NKTK Nkarta, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| CVRX CVRx, Inc. | A Award deriv | 2023-06-05 | 2023-06-07 | 12,012 | — | $0 | 12,012 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2023-06-01 | 2023-06-05 | 28 | — | $0 | 85 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2023-06-01 | 2023-06-05 | 113 | — | $0 | 339 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2023-05-16 | 2023-05-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2023-03-16 | 2023-03-20 | 7,111 | $1.67 | $11.9K | 35,115 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | D To issuer deriv | 2023-01-03 | 2023-01-04 | 5,359 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | D To issuer deriv | 2023-01-03 | 2023-01-04 | 5,199 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | D To issuer | 2023-01-03 | 2023-01-04 | 3,573 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | D To issuer | 2023-01-03 | 2023-01-04 | 10,066 | — | $0 | 3,573 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2022-12-20 | 2022-12-22 | 57 | — | $0 | 57 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2022-12-20 | 2022-12-22 | 226 | — | $0 | 226 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2022-12-16 | 2022-12-19 | 7,917 | $1.50 | $11.9K | 28,004 | SEC↗ |
| AKUS Akouos, Inc. | U Tender | 2022-11-30 | 2022-12-02 | 4,294,207 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-10-17 | 2022-10-19 | 37,700 | $1000.00 | $37.70M | 37,700 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-10-17 | 2022-10-19 | 100,000 | $1000.00 | $100.00M | 100,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2022-09-16 | 2022-09-19 | 4,532 | $2.62 | $11.9K | 20,087 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-07-01 | 2022-07-01 | 737,050 | — | $0 | 737,050 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2022-06-17 | 2022-06-17 | 5,850 | $2.03 | $11.9K | 15,555 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2022-06-15 | 2022-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2022-06-10 | 2022-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| UTRS MINERVA SURGICAL INC | A Award | 2022-06-10 | 2022-06-14 | 49,792 | $2.41 | $120.0K | 58,279 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2022-06-09 | 2022-06-10 | 12,000 | — | $0 | 12,000 | SEC↗ |
| NKTK Nkarta, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CVRX CVRx, Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 26,985 | — | $0 | 26,985 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award deriv | 2022-06-06 | 2022-06-08 | 5,359 | — | $0 | 5,359 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award | 2022-06-06 | 2022-06-08 | 3,573 | — | $0 | 13,639 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2022-04-11 | 2022-04-13 | 3,000,000 | $1.90 | $5.70M | 3,000,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2022-04-11 | 2022-04-13 | 948,948 | $1.90 | $1.80M | 948,948 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2022-04-11 | 2022-04-13 | 2,631,578 | $1.90 | $5.00M | 10,421,428 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2022-03-18 | 2022-03-18 | 4,346 | $3.02 | $13.1K | 9,705 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-01-03 | 2022-01-05 | 75,000 | $1000.00 | $75.00M | 75,000 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy deriv | 2022-01-03 | 2022-01-05 | 125,000 | $1000.00 | $125.00M | 125,000 | SEC↗ |
| MTCR | S Sale | 2021-12-22 | 2021-12-27 | 170,932 | $0.91 | $155.5K | 2,563,257 | SEC↗ |
| MTCR | S Sale | 2021-12-22 | 2021-12-27 | 288,768 | $1.00 | $288.8K | 2,734,189 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2021-12-17 | 2021-12-17 | 2,472 | $5.31 | $13.1K | 5,359 | SEC↗ |
| MTCR | S Sale | 2021-12-10 | 2021-12-27 | 37,570 | $1.32 | $49.6K | 3,022,957 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 0 | — | $0 | 2,084 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 0 | — | $0 | 1,583 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 0 | — | $0 | 2,564 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 0 | — | $0 | 3,306 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 0 | — | $0 | 0 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 281 | — | $0 | 0 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 704 | — | $0 | 0 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 4,196 | — | $0 | 0 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 544 | — | $0 | 0 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 523 | — | $0 | 0 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 516 | — | $0 | 0 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 501 | — | $0 | 0 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 480 | — | $0 | 0 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 742 | — | $0 | 0 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 3,306 | — | $0 | 544 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion deriv | 2021-10-26 | 2021-10-28 | 0 | — | $0 | 1,067 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion | 2021-10-26 | 2021-10-28 | 4,196 | — | $0 | 5,181 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion | 2021-10-26 | 2021-10-28 | 3,306 | — | $0 | 8,487 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion | 2021-10-26 | 2021-10-28 | 281 | — | $0 | 281 | SEC↗ |
| UTRS MINERVA SURGICAL INC | C Conversion | 2021-10-26 | 2021-10-28 | 704 | — | $0 | 985 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 1,851,852 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 1,851,852 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 7,789,850 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2021-09-17 | 2021-09-23 | 1,326 | $9.90 | $13.1K | 2,887 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2021-07-01 | 2021-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2021-07-01 | 2021-07-02 | 474,385 | — | $0 | 474,385 | SEC↗ |
| CVRX CVRx, Inc. | A Award deriv | 2021-06-29 | 2021-07-01 | 10,382 | — | $0 | 10,382 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,361,912 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 9,588,725 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 11,500,000 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,224,428 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 4,980,687 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,448,856 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,954,906 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 12,712,399 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 3,257,328 | — | $0 | 5,973,296 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 2,715,968 | — | $0 | 2,715,968 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | P Buy | 2021-06-28 | 2021-06-30 | 1,050,000 | $19.00 | $19.95M | 7,692,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 669,002 | — | $0 | 6,642,298 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 7,346,568 | — | $0 | 22,288,629 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 14,942,061 | — | $0 | 14,942,061 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy | 2021-06-28 | 2021-06-30 | 1,694,444 | $18.00 | $30.50M | 23,983,073 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy | 2021-06-28 | 2021-06-30 | 250,000 | $18.00 | $4.50M | 47,925,199 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 5,864,718 | — | $0 | 5,864,718 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 38,137,197 | — | $0 | 44,001,915 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 3,673,284 | — | $0 | 47,675,199 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2021-06-23 | 2021-06-25 | 47,132 | — | $0 | 47,132 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2021-06-18 | 2021-06-22 | 1,014 | $12.95 | $13.1K | 1,561 | SEC↗ |
| NKTK Nkarta, Inc. | A Award deriv | 2021-06-13 | 2021-06-15 | 16,511 | — | $0 | 16,511 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2021-06-10 | 2021-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award deriv | 2021-06-07 | 2021-06-09 | 5,199 | — | $0 | 5,199 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award | 2021-06-07 | 2021-06-09 | 3,466 | — | $0 | 10,066 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award | 2021-03-18 | 2021-03-22 | 547 | $24.01 | $13.1K | 547 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2020-12-04 | 2020-12-07 | 5,239,254 | $0.13 | $681.1K | 5,239,254 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2020-12-04 | 2020-12-07 | 258,707 | $6.22 | $1.61M | 258,707 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2020-12-04 | 2020-12-07 | 4,398,602 | $0.62 | $2.73M | 6,451,056 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 1,958,333 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 332,964 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 1,958,333 | — | $0 | 1,958,333 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 332,964 | — | $0 | 2,291,297 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 769,230 | $13.00 | $10.00M | 3,060,527 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2020-08-13 | 2020-08-14 | 14 | — | $0 | 14 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2020-08-13 | 2020-08-14 | 57 | — | $0 | 256 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| NKTK Nkarta, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 10,700 | — | $0 | 10,700 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2020-07-01 | 2020-07-01 | 184,258 | — | $0 | 184,258 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,199,976 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,992,238 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 513,758 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,992,238 | — | $0 | 2,505,996 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,199,976 | — | $0 | 3,705,972 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-01 | 588,235 | $17.00 | $10.00M | 4,294,207 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 513,758 | — | $0 | 513,758 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2020-06-18 | 2020-06-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2020-06-11 | 2020-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award | 2020-06-08 | 2020-06-10 | 6,600 | — | $0 | 6,600 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | X Exercise deriv | 2020-04-03 | 2020-04-13 | 1,500,000 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | X Exercise | 2020-04-03 | 2020-04-13 | 1,500,000 | — | $0 | 5,938,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2020-04-03 | 2020-04-13 | 564 | $2.66 | $1.5K | 5,937,998 | SEC↗ |
| BDTX Black Diamond Therapeutics | C Conversion deriv | 2020-02-03 | 2020-02-05 | 6,565,290 | — | $0 | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | C Conversion deriv | 2020-02-03 | 2020-02-05 | 1,422,862 | — | $0 | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | C Conversion | 2020-02-03 | 2020-02-05 | 471,800 | — | $0 | 2,648,757 | SEC↗ |
| BDTX Black Diamond Therapeutics | P Buy | 2020-02-03 | 2020-02-05 | 800,000 | $19.00 | $15.20M | 3,448,757 | SEC↗ |
| BDTX Black Diamond Therapeutics | C Conversion | 2020-02-03 | 2020-02-05 | 2,176,957 | — | $0 | 2,176,957 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2020-01-24 | 2020-01-28 | 7,500,000 | $0.67 | $5.03M | 19,500,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 9,009,000 | $0.13 | $1.17M | 9,009,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 900,900 | $6.66 | $6.00M | 900,900 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 29,889,945 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 450,000 | $15.00 | $6.75M | 4,186,243 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 3,736,243 | — | $0 | 3,736,243 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2019-07-18 | 2019-07-19 | 5,625 | — | $0 | 5,625 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2019-07-02 | 2019-07-03 | 234,407 | — | $0 | 234,407 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 17,099,315 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,500,000 | $10.00 | $15.00M | 4,438,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 1,938,562 | — | $0 | 1,938,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,000,000 | $10.00 | $10.00M | 2,938,562 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 3,703,704 | $0.13 | $481.5K | 3,703,704 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 256,700 | $10.80 | $2.77M | 256,700 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2019-05-07 | 2019-05-09 | 1,136,704 | $1.08 | $1.23M | 2,052,454 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-09-07 | 2018-09-10 | 12,000,000 | $1.67 | $20.04M | 12,000,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2018-06-22 | 2018-06-26 | 154,809 | — | $0 | 154,809 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2018-06-21 | 2018-06-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2018-06-15 | 2018-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2018-05-21 | 2018-05-23 | 3,785 | — | $0 | 5,390 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2018-05-14 | 2018-05-15 | 199 | — | $0 | 199 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2018-02-08 | 2018-02-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NVRO NEVRO CORP | J Other | 2017-09-14 | 2017-09-15 | 8 | — | $0 | 1,605 | SEC↗ |
| NVRO NEVRO CORP | J Other | 2017-09-14 | 2017-09-15 | 32 | — | $0 | 1,597 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2017-07-03 | 2017-07-03 | 220,788 | — | $0 | 220,788 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2017-05-31 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2017-05-25 | 2017-05-30 | 3,545 | — | $0 | 3,545 | SEC↗ |
| NVRO NEVRO CORP | A Award | 2017-05-25 | 2017-05-30 | 1,518 | — | $0 | 1,565 | SEC↗ |
| NVRO NEVRO CORP | J Other | 2016-11-11 | 2016-11-15 | 3 | — | $0 | 47 | SEC↗ |
| NVRO NEVRO CORP | J Other | 2016-11-11 | 2016-11-15 | 19 | — | $0 | 44 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2016-10-18 | 2016-10-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2016-08-11 | 2016-08-12 | 184,562 | — | $0 | 184,562 | SEC↗ |
| NVRO NEVRO CORP | A Award deriv | 2016-05-18 | 2016-05-20 | 3,240 | — | $0 | 3,240 | SEC↗ |
| NVRO NEVRO CORP | J Other | 2015-12-02 | 2015-12-03 | 22 | — | $0 | 22 | SEC↗ |